London, (Zahid Anwar Mirza) — Thousands of men across the UK are set to benefit from a newly approved prostate cancer treatment after the National Health Service (NHS) granted funding for a breakthrough drug that can reduce the risk of death by up to 50 percent.

Under the new decision, more than 7,000 additional men each year will gain access to the life-saving medication. Campaigners have hailed the move as a “historic victory,” estimating that the drug could help save up to 3,000 lives.

Health experts and patient advocacy groups have long been calling for wider availability of this treatment, arguing that it significantly lowers the risk of death caused by prostate cancer. The approval marks a major milestone in improving outcomes for patients suffering from one of the most common cancers affecting men.

The NHS decision is being widely welcomed as a significant advancement in the fight against prostate cancer, offering renewed hope to thousands of patients and their families across the country.